Todralazine

CAS : 14679-73-3

Ref. 3D-PAA67973

Informations sur le produit

• Nom: Todralazine
• Synonymes: 2-(1-Phthalazinyl)Hydrazinecarboxylic acid ethyl ester, 3-(1-Phthalazinyl)carbazic acid ethyl ester, Brn 0233300, Bt 621, Carbazic acid, 3-(1-phthalazinyl)-, ethyl ester, Carboethoxyphthalazinohydrazine, Ethyl 2-(Phthalazin-1-Yl)Hydrazinecarboxylate, Ethyl 2-(Phthalazin-1-Yl)Hydrazinecarboxylate Hydrochloride (1:1), Ethyl 3-(1-phthalazinyl)carbazate, Hydrazinecarboxylic acid, 2-(1-phthalazinyl)-, ethyl ester, Hydrazinecarboxylic acid, 2-(1-phthalazinyl)-, ethyl ester (9CI), N-Carboethoxy-N'-phthalazino-hydrazine, N¹-Carbethoxy-N²-phthalazinehydrazine, Todralacina, Todralacina [Spanish], Todralazina, Todralazina [INN-Spanish], Todralazine [INN:BAN], Todralazinum, Todralazinum [INN-Latin], Unii-Wen3K83Ykd, N1-Carbethoxy-N2-phthalazinehydrazine

Description

Todralazine is a potassium dichromate salt that is used for the treatment of inflammatory bowel disease. Todralazine is an anti-inflammatory drug and has been shown to reduce the production of cytokines, such as IL-1β and IL-6, in human serum. Todralazine also inhibits genotoxic activity by suppressing reactive oxygen species (ROS) production. Todralazine may be able to stabilize chemical reactions, which can be useful in biocompatible polymers. It has been shown to be effective in congestive heart failure; however, it can cause bowel disease if taken long term.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 232.24 g/mol
• Formule: C₁₁H₁₂N₄O₂
• Degré de pureté: Min. 95%